B · Normal
[Yisheng Pharmaceutical: Received Notice of Lifting Risk Control Measures and Relevant Production Lines Will Resume Orderly] On September 21, Yisheng Pharmaceutical (002566.SZ) announced that the company received the "Notice of Lifting Risk Control Measures" issued by the Jilin Provincial Food and Drug Administration today. After on-site inspection, it was confirmed that safety hazards have been eliminated and the company agreed to lift the risk control measures. After the risk control measures are lifted, the relevant production lines will resume production in an orderly manner, resume production as planned and ensure market supply, which will not have a significant adverse impact on the company's current operating performance.
Comments